ABUS vs LOW
Arbutus Biopharma Corp (ABUS) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the ABUS and LOW stock pages for the full models.
Not investment advice.